Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
3 Downloads (Pure)
Original languageEnglish
Article number1756284820979765
JournalTherapeutic Advances in Gastroenterology
Volume13
DOIs
Publication statusPublished - 2020

Cite this